Skip to content
lifestyle.infotechinc.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Bavarian Nordic A/S
Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years
August 7, 2026
Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil
July 13, 2026
Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
June 29, 2026
Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine
June 9, 2026